---
layout: post
title: AASLD 2014 HBV Post Conference Update 11-21-14
date: 2014-11-21 10:00:00
tags:
    - hbv
    - treatment
---

![](/assets/images/aasld-2014-hbv-post-conference-update-11-21-14.jpg)

65th Annual Meeting of the American Association for the Study of Liver Diseases: Post Conference HBV Update - Robert G. Gish MD and the Practice Point Team at Simply Speaking

Upon completion of this educational activity, participants should be able to:

 –

Screen for hepatitis B virus (HBV) infection according to the recommendations

from the American Association for the Study of Liver Diseases (AASLD) and theCenters for Disease Control and Prevention (CDC)

 –

Appropriately select antiviral HBV treatment strategies for according to the recommendations from the AASLD guidelines

 –

Manage safety and tolerability problems with antiviral HBV agents, includingside effect, drug-drug interactions, and resistance

 –

Evaluate new agents being investigated for HBV therapy to optimizeinformation-based decision making about therapy